S., T., & K., J. (2014). Ifosfamide, epirubicin and cisplatin (IEP): Another active combination for small cell lung cancer (SCLC).
Chicago Style CitationS., Thongprasert, and Jiamsriponges K. Ifosfamide, Epirubicin and Cisplatin (IEP): Another Active Combination for Small Cell Lung Cancer (SCLC). 2014.
MLA CitationS., Thongprasert, and Jiamsriponges K. Ifosfamide, Epirubicin and Cisplatin (IEP): Another Active Combination for Small Cell Lung Cancer (SCLC). 2014.
Warning: These citations may not always be 100% accurate.